Skip to content
Menu

Kiniksa Pharmaceuticals International, plc KNSA

Full chart Compare
Set alert

Price alert · KNSA

All alert types
95.04 USD +0.81 (+0.86%)

As ofNov 17, 2026, 9:58 AM EST

93.50 Day range 95.70
37.02 52-week range 99.31
YTD
+130.40%
1 year
+129.57%

Revenue & Expenses

Revenue Profit Costs
Other Income$11.65MOther Operating Income$196.00KGross Profit$370.15MCost of Revenue$307.41MGross Profit & Other Income$381.99MNet Income$59.01MSelling, General & Admin$196.27MResearch & Development$96.85MIncome Tax$29.86MRevenue$677.56M

Latest period ending Dec 31, 2025 · select a line to chart its full history

KNSA annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
677.56M423.24M270.26M220.18M38.54M
599.89M362.33M236.85M197.28M29.44M
77.22M-45.62M-25.20M9.77M-156.64M
59.01M-43.19M14.08M183.36M-157.92M
0.75-0.600.202.60-2.30
KNSA annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
165.60M183.58M107.95M122.72M122.47M
763.63M580.55M526.32M459.67M232.80M
196.03M142.12M87.48M63.52M47.76M
9.50M9.86M12.26M5.92M6.05M
567.61M438.44M438.84M396.15M185.04M
KNSA annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
137.99M25.69M13.30M5.81M-126.30M
-188.99M37.67M-29.56M-8.08M128.63M
33.02M12.27M1.50M2.52M5.88M
-1.57M-252.00K-130.00K-14.00K-415.00K
-17.98M75.63M-14.76M245.00K8.22M